Accelera is providing support to the development of new bio-therapeutics performing a number of critical assessments on large molecules, including pharmacokinetics, pharmacodynamics and immunogenicity testing.

Bioassays are developed at each stage of development taking into account the characteristics of the test molecule and the required level of throughput, sensitivity, sample volume, as in the following example:

PEGilated protein drug candidate